BACKGROUND: Immunoadsorption (IA) is used in patients with chronic inflammatory dilative cardiomyopathy (iDCM) to remove cardiotoxic autoantibodies, and to improve myocardial function. We examined the effects of IA on endothelial function, circulating endothelial progenitor cells, and circulating microparticles, including endothelial-derived microparticles, in patients with chronic iDCM. METHODS: Thirteen patients (10 males, 3 females, mean age 52.3 years) with advanced congestive heart failure (NYHA III and IV) secondary due to chronic iDCM (with signs of myocardial inflammation in biopsies, but without persistence of virus genome), and reduced left ventricular ejection fraction (EF < 35%) underwent IA. Blood samples were drawn before an IA course of 5 days, and 6 months after IA. Blood levels of endothelial progenitor cells (EPCs as defined as VEGFR2(+)CD34(+) cells), of microparticles (MPs as defined as Annexin V(+) particles with a diameter between 0.1 and 1 μm), and of endothelial-derived MPs (eMPs as defined as CD31(+bright) CD42b(-)/Annexin V(+) particles) were analyzed by flow cytometry. Endothelial function (expressed as reactive hyperemia index (RHI)) and arterial stiffness were assessed by PAT-technology (peripheral arterial tone) using fingertips. RESULTS: Left ventricular systolic function (EF%) improved on average at 6 months from 26.3 ± 4.8 to 37.9 ± 9.6% (mean ± SEM; p < 0.05). The LV end-diastolic diameter reduced after 6 months from 68.4 ± 8.2 to 61.6 ± 7.9 mm; p < 0.05). Endothelial function improved from 1.53 ± 0.09 to 1.80 ± 0.12 (p < 0.05). The arterial stiffness index remained unchanged. Number of total MPs decreased on average by 36.8% (p < 0.05), the number of eMPs by 39.6% (p < 0.05), respectively. The level of circulating EPC remained unchanged (EPC/PMNC 0.26 ± 0.07 vs. 0.27 ± 0.05 ‰, p = n.s.). CONCLUSIONS: IA treatment improves endothelial function in patients with chronic iDCM. This effect is associated with a significant drop in circulating microparticles. The causal relationship between circulating microparticles and endothelial function is discussed.
BACKGROUND: Immunoadsorption (IA) is used in patients with chronic inflammatory dilative cardiomyopathy (iDCM) to remove cardiotoxic autoantibodies, and to improve myocardial function. We examined the effects of IA on endothelial function, circulating endothelial progenitor cells, and circulating microparticles, including endothelial-derived microparticles, in patients with chronic iDCM. METHODS: Thirteen patients (10 males, 3 females, mean age 52.3 years) with advanced congestive heart failure (NYHA III and IV) secondary due to chronic iDCM (with signs of myocardial inflammation in biopsies, but without persistence of virus genome), and reduced left ventricular ejection fraction (EF < 35%) underwent IA. Blood samples were drawn before an IA course of 5 days, and 6 months after IA. Blood levels of endothelial progenitor cells (EPCs as defined as VEGFR2(+)CD34(+) cells), of microparticles (MPs as defined as Annexin V(+) particles with a diameter between 0.1 and 1 μm), and of endothelial-derived MPs (eMPs as defined as CD31(+bright) CD42b(-)/Annexin V(+) particles) were analyzed by flow cytometry. Endothelial function (expressed as reactive hyperemia index (RHI)) and arterial stiffness were assessed by PAT-technology (peripheral arterial tone) using fingertips. RESULTS:Left ventricular systolic function (EF%) improved on average at 6 months from 26.3 ± 4.8 to 37.9 ± 9.6% (mean ± SEM; p < 0.05). The LV end-diastolic diameter reduced after 6 months from 68.4 ± 8.2 to 61.6 ± 7.9 mm; p < 0.05). Endothelial function improved from 1.53 ± 0.09 to 1.80 ± 0.12 (p < 0.05). The arterial stiffness index remained unchanged. Number of total MPs decreased on average by 36.8% (p < 0.05), the number of eMPs by 39.6% (p < 0.05), respectively. The level of circulating EPC remained unchanged (EPC/PMNC 0.26 ± 0.07 vs. 0.27 ± 0.05 ‰, p = n.s.). CONCLUSIONS: IA treatment improves endothelial function in patients with chronic iDCM. This effect is associated with a significant drop in circulating microparticles. The causal relationship between circulating microparticles and endothelial function is discussed.
Authors: Daniel Bulut; Nadine Albrecht; Matthias Imöhl; Bülent Günesdogan; Nadine Bulut-Streich; Jan Börgel; Christoph Hanefeld; Michael Krieg; Andreas Mügge Journal: Clin Res Cardiol Date: 2007-02-26 Impact factor: 5.460
Authors: Elif Seda Selamet Tierney; Jane W Newburger; Kimberlee Gauvreau; Judith Geva; Elizabeth Coogan; Steven D Colan; Sarah D de Ferranti Journal: J Pediatr Date: 2009-02-12 Impact factor: 4.406
Authors: Stuart D Katz; Katarzyna Hryniewicz; Ingrid Hriljac; Kujtim Balidemaj; Clarito Dimayuga; Alhakam Hudaihed; Aleksandr Yasskiy Journal: Circulation Date: 2005-01-17 Impact factor: 29.690
Authors: Daniel Bulut; Michael Scheeler; Tim Wichmann; Jan Börgel; Thomas Miebach; Andreas Mügge Journal: Clin Res Cardiol Date: 2010-04-25 Impact factor: 5.460
Authors: Andreas O Doesch; Mathias Konstandin; Sultan Celik; Arnt Kristen; Lutz Frankenstein; Stefan Hardt; Stefan Goeser; Ziya Kaya; Hugo A Katus; Thomas J Dengler Journal: J Clin Apher Date: 2009 Impact factor: 2.821
Authors: Alexander Sedaghat; Jan-Malte Sinning; Kathrin Paul; Gregor Kirfel; Georg Nickenig; Nikos Werner Journal: Clin Res Cardiol Date: 2013-02-10 Impact factor: 5.460
Authors: Monica Lisi; Matthias Oelze; Saverio Dragoni; Andrew Liuni; Sebastian Steven; Mary-Clare Luca; Dirk Stalleicken; Thomas Münzel; Franco Laghi-Pasini; Andreas Daiber; John D Parker; Tommaso Gori Journal: Clin Res Cardiol Date: 2012-06 Impact factor: 5.460
Authors: Maria de Lourdes Higuchi; Joyce T Kawakami; Renata N Ikegami; Marcia M Reis; Jaqueline de Jesus Pereira; Barbara M Ianni; Paula Buck; Luanda Mara da Silva Oliveira; Marilia H H Santos; Ludhmila A Hajjar; Edimar A Bocchi Journal: Front Cell Infect Microbiol Date: 2018-11-21 Impact factor: 5.293
Authors: Sabine Ameling; Gourav Bhardwaj; Elke Hammer; Daniel Beug; Leif Steil; Yvonne Reinke; Kerstin Weitmann; Markus Grube; Christiane Trimpert; Karin Klingel; Reinhard Kandolf; Wolfgang Hoffmann; Matthias Nauck; Marcus Dörr; Klaus Empen; Stephan B Felix; Uwe Völker Journal: Basic Res Cardiol Date: 2016-07-13 Impact factor: 17.165
Authors: Sabine Ameling; Lars R Herda; Elke Hammer; Leif Steil; Alexander Teumer; Christiane Trimpert; Marcus Dörr; Heyo K Kroemer; Karin Klingel; Reinhard Kandolf; Uwe Völker; Stephan B Felix Journal: Eur Heart J Date: 2012-10-25 Impact factor: 29.983